Earnings Analyzer
Stock earnings page

MEDTRONIC PLC (MDT)

Track the next or latest earnings date for MEDTRONIC PLC, review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics? — TradingView News
www.tradingview.com · 20 hours ago

We expect the news to boost market sentiment toward MDT stock in the upcoming days. Medtronic presently has a market capitalization of $100.34 billion. The company’s earnings yield of 7.8% compares with the industry’s 3.1%. It delivered a trailing four-quarter average earnings surprise of 2.8%.

Is It Time To Reconsider Medtronic (MDT) After Recent Share Price Weakness?
finance.yahoo.com · 11 hours ago

With Medtronic stock trading at around US$78.60, this article walks through the key numbers so you can judge for yourself whether the current price offers fair value or a potential discount. Over shorter periods the stock has been mixed, up 3.2% over the last week, but down 5.6% over the last ...

Medtronic PLC $MDT Shares Acquired by Handelsbanken Fonder AB
www.marketbeat.com · 4 days ago

Handelsbanken Fonder AB boosted its holdings in Medtronic PLC (NYSE:MDT - Free Report) by 7.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 669,085 shares of the medical technology company's stock after buy

Medtronic Announces Leadership Transition in Neuroscience Portfolio - TipRanks.com
www.tipranks.com · 5 days ago

To see the full list of analyst forecasts on Medtronic stock, see the MDT Stock Forecast page. ... According to Spark, TipRanks’ AI Analyst, MDT is a Neutral. MDT scores as above-average primarily due to solid financial performance anchored by strong free cash flow and a constructive earnings-c...

Medtronic stock (IE00BTN1Y115): focus on diabetes spin-off and latest quarterly results
www.ad-hoc-news.de · 4 days ago

Medtronic is reshaping its portfolio with the proposed spin-off of its patient monitoring and respiratory interventions business while reporting solid quarterly figures. What does this mean for the medical technology group’s revenue mix and its role for US healthcare investors?

Latest earnings date

Feb 17, 2026

Pre-market

Fiscal quarter: 2026-01-31

EPS estimate: $1.33

Revenue estimate: N/A

Market cap: $127.55B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 17, 2026 2026-01-31 Pre-market $1.33 N/A